Yes, for many patients, medical weight loss offers an effective, non-surgical alternative to bariatric surgery
Trends in first-time prescribing and dispensing First-time prescribing rates (first-time GLP-1 RA prescriptions per total prescriptions) in December 2023 were slightly lower than rates in November 2023 and October 2023
In September 2025, clinical research was published on weight loss for two oral incretin therapies: an oral version of semaglutide and Orforglipron, also a GLP-1 receptor agonist
(PubMed) Collins R, Peto R, Armitage J
Ali, Mennatallah A., Rasha A
How It Works Compounded Semaglutide (GLP-1) is a once-weekly injectable medication that mimics a natural hormone involved in appetite regulation and blood sugar control